Annual CAPEX
N/A
31 December 2022
Summary:
Zynerba Pharmaceuticals annual capital expenditures is not available.ZYNE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly capital expenditures is not available.ZYNE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 June 2023
Summary:
Zynerba Pharmaceuticals TTM capital expenditures is not available.ZYNE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ZYNE CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Zynerba Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $286.70 K(+148.4%) | $129.20 K(+224.6%) | $286.60 K(+57.7%) |
| Sept 2018 | - | $39.80 K(-60.3%) | $181.70 K(+17.4%) |
| June 2018 | - | $100.20 K(+475.9%) | $154.80 K(+141.1%) |
| Mar 2018 | - | $17.40 K(-28.4%) | $64.20 K(-44.4%) |
| Dec 2017 | $115.40 K(+5.3%) | $24.30 K(+88.4%) | $115.40 K(+1.2%) |
| Sept 2017 | - | $12.90 K(+34.4%) | $114.00 K(-28.4%) |
| June 2017 | - | $9600.00(-86.0%) | $159.30 K(+6.4%) |
| Mar 2017 | - | $68.60 K(+199.6%) | $149.70 K(+36.6%) |
| Dec 2016 | $109.60 K | $22.90 K(-60.7%) | $109.60 K(-13.6%) |
| Sept 2016 | - | $58.20 K(>+9900.0%) | $126.90 K(-36.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $0.00(-100.0%) | $198.50 K(-16.8%) |
| Mar 2016 | - | $28.50 K(-29.1%) | $238.50 K(+10.3%) |
| Dec 2015 | $216.30 K(+998.0%) | $40.20 K(-69.0%) | $216.30 K(+19.9%) |
| Sept 2015 | - | $129.80 K(+224.5%) | $180.40 K(+196.2%) |
| June 2015 | - | $40.00 K(+534.9%) | $60.90 K(+134.2%) |
| Mar 2015 | - | $6300.00(+46.5%) | $26.00 K(+32.0%) |
| Dec 2014 | $19.70 K(+629.6%) | $4300.00(-58.3%) | $19.70 K(+27.9%) |
| Sept 2014 | - | $10.30 K(+102.0%) | $15.40 K(+202.0%) |
| June 2014 | - | $5100.00 | $5100.00 |
| Dec 2013 | $2700.00 | - | - |
FAQ
- What is the all time high annual CAPEX for Zynerba Pharmaceuticals?
- What is the all time high quarterly CAPEX for Zynerba Pharmaceuticals?
- What is the all time high TTM CAPEX for Zynerba Pharmaceuticals?
What is the all time high annual CAPEX for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual capital expenditures is $286.70 K
What is the all time high quarterly CAPEX for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly capital expenditures is $129.80 K
What is the all time high TTM CAPEX for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high TTM capital expenditures is $286.60 K